Sort by

Send to

Choose Destination

Links from PubMed

Items: 5


CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.

Nayak JL, Fitzgerald TF, Richards KA, Yang H, Treanor JJ, Sant AJ.

J Infect Dis. 2013 Jan 15;207(2):297-305. doi: 10.1093/infdis/jis684. Epub 2012 Nov 12.


Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.


A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, Webby RJ.

PLoS One. 2011;6(10):e26335. doi: 10.1371/journal.pone.0026335. Epub 2011 Oct 24.


Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Mahnke YD, Saqr A, Hazenfeld S, Brady RC, Roederer M, Subbramanian RA.

Vaccine. 2011 Nov 3;29(47):8606-14. doi: 10.1016/j.vaccine.2011.09.019. Epub 2011 Sep 20.


Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.

Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Jacob J, Prausnitz MR, Compans RW, Skountzou I.

J Infect Dis. 2011 Aug 15;204(4):582-91. doi: 10.1093/infdis/jir094. Epub 2011 Jun 17.

Supplemental Content

Support Center